World Pharma 2024 [Past Report]
November 18 & 19, 2024 (Virtual)
World Pharma 2024 -[Past Report]
5th Global Virtual Summit on Pharmaceutical and Novel Drug Delivery Systems
November 18 & 19, 2024
World Pharma 2024 Keynote Presenters
November 18 & 19, 2024
Sofica Bistriceanu, MD, PhD
European Primary Care Cardiovascular Society, Romania
Abstract Title:
Monitoring Fluid Administration in Heart Failure Clinically
Dr. Muhammad Salman
Balfour Hospital, Orkney, UK
Abstract Title:
Relationship of hyperbilirubinemia and hypoalbuminemia with fibroscan in various stages of fibrosisin rna positive hcv infected patients
Kenneth A. Jacobson
National Institutes of Health, USA
Abstract Title:
Interaction of adenosine receptors and ligands with the membrane environment
Thomas J. Webster
Hebei University of Technology, China
Abstract Title:
The Impact of Nanomedicine: 30,000 Orthopedic Nano Implants With No Failures and Still Counting
Prof. Imran Saleem
Liverpool John Moores University, Uk
Abstract Title:
Non-Parenteral Administration of Biologicals using Nanocarrier Systems
World Pharma 2024 Oral Presenters
November 18 & 19, 2024
A.I. Fraguas-Sánchez
Complutense University, Spain
Abstract Title:
Targeted delivery of silibinin via polymeric nanoparticles: potential application in cancer disease
Antonella De Angelis
University of Campania “Luigi Vanvitelli”, Naples, Italy
Abstract Title:
Effects of sacubitril-valsartan alone or in combination with dapagliflozin on aging-related heart failure with preserved ejection fraction
Dr. Waad Samman
Taibah University College of Pharmacy, Saudi Arabia
Abstract Title:
Dapagliflozin Ameliorates Cognitive Impairment in Aluminum-Chloride-Induced Alzheimer’s Disease via Modulation of AMPK/mTOR, Oxidative Stress and Glucose Metabolism
Dr.Mary Anbarasi Johnson
CMC Vellore, India
Abstract Title:
Medical and Nursing Mangement of child with IDDM
Mirjana B. Čolović
University of Belgrade, Republic of Serbia
Abstract Title:
Metal-based nanoclusters: enzyme interaction as a putative mode of biological activity
James J. Hickman
University of Central Florida, USA
Abstract Title:
Human-on-a-chip systems as pre-clinical models for neurological diseases and disorders
Fleisher-Berkovich Sigal
Ben-Gurion University of the Negev, Israel
Abstract Title:
Multiple sclerosis is modulated by cannabigerol and standardized cannabis strains
Tarek Kamal Motawi
Cairo University, Egypt
Abstract Title:
Potential serum biomarkers for early detection of diabetic nephropathy
Shaukat Ali
Ascendia Pharma, Inc., USA
Abstract Title:
Lipid Nanoparticles – A enabling technology for delivery of small molecules and biologics
Dr. John K. Maesaka
NYU Grossman Long Island School of Medicine, USA
Abstract Title:
New pathophysiologic approach to hyponatremia yields revolutionary results, iden
Prof. Vladimír Zajac, PhD.
Institute of Cancer Research, Slovakia
Abstract Title:
Detection and elimination of viral pathogens in the intestinal tract after overcoming infection. New Medicine.
Vasily Lutsyk
Siberian Branch of the Russian Academy of Sciences, Russia
Abstract Title:
Assembly of spatial computer models for T-x1-x2 diagrams with polymorph pharmaceutical compounds
Mohammad Kamil
General Lotus Holistic Institute, UAE
Abstract Title:
New Natural Products from Plants with Special Reference to Novel Flavonoids, Biflavonoids and their Biological Implications
Sergey Suchkov
The Russian University of Medicine, Russia
Abstract Title:
The Promise of Nanotechnology in Personalized & Precision Medicine: Drug Discovery & Development being partnered with Nanotechnologies via the Revolution at the Nanoscale
Mark Gaynor
Saint Louis University, USA
Abstract Title:
Blockchain Applications in the Pharmaceutical Industry
Sabu Thomas
Mahatma Gandhi University, India
Abstract Title:
Development of Polymer Nanocomposite Scaffolds for Tissue Engineering
Yongzhao Su
Zhejiang University, China
Abstract Title:
Cell-Selective and Transcytosable Iron Oxide Nanoparticles (TION) Matching Cell Heterogeneity for Tissue-Penetrating Imaging
Liang Xu
University of Kansas Cancer Center, USA
Abstract Title:
Heating up “cold” tumor — Repurposing Niclosamide to improve cancer immunotherapy by targeting RNA-binding protein HuR
William A. Eaton, MD, PhD
National Institutes of Health, Bethesda, MD, USA
Abstract Title:
Problems encountered following discovery of drug candidates in Scripps ReFrame drug repurposing library
Richard Visser D.C., PhD.
Former Minister of Health and Sports, Aruba
Abstract Title:
The Aruba Project: Integrating Movement, Nutrition, and Mental Health for Holistic Youth Wellness in a Post-Pandemic World
A.James Mixson
University of Maryland Baltimore, USA
Abstract Title:
A simple, innovative siRNA delivery platform for solid tumors
Jagessar
University of Guyana, Guyana
Abstract Title:
Can plant ethanolic extracts can be used as selective antimicrobial agents against S. aureus.?
Umesh R. Desai
Virginia Commonwealth University, USA
Abstract Title:
Synthetic, Sulfated Agents As Anti-Factor XIa Antithrombotics
Bikash Kumar Sah
Purbanchal University College of Medical and Allied Sciences, Nepal
Abstract Title:
Uropathogens and their antimicrobial-resistant pattern among suspected urinary tract infections patients in eastern Nepal: A hospital inpatients-based study.
Mr. Richard Stead
QURES GROUP LTD, UK
Abstract Title:
Throw away your Probiotics – they may be dangerous!
Prof. Abdelmonem Awad Hegazy
Zarqa University, Jordan
Abstract Title:
New role of antiparasitic drug ivermectin in fighting COVID-19
World Pharma 2024 Poster Presenters
November 18 & 19, 2024
Marwah Habib Alhamadah
Imam Abdulrahman Bin Faisal University, Saudi Arabia
Abstract Title:
Exploring FDA-Approved Drugs as Shikimate Kinase Inhibitors Against Acinetobacter baumannii: A Computational Drug Repurposing Approach